The 2026 Access to Justice Network Conference is now open for session proposals! If you’re building, researching, organizing, or imagining new ways to expand access to justice, this is your space.
📅 Oct 20–22, 2026 - Cincinnati
📝 Proposal form: buff.ly/qFx1OGl
⏳ Due Jan 7
#Access2Justice #SLRN
#teamchastity #teamlocked #owned #slrn #slavereg #cagecheck #lockedsub #collared #caged #gaychastity
In an Apr 28 letter, Trium urges liquidation, citing higher shareholder value and lower risk. Acelyrin #SLRN rejected a $3/share buyout from Tang Capital, pushing for the merger, set to close Q2 2025.
#SLRN Alumis and ACELYRIN Announce Amended Merger Agreement
www.stocktitan.net/news/SLRN/alumis-and-ace...
#SLRN ACELYRIN Adopts Limited-Duration Stockholder Rights Plan
www.stocktitan.net/news/SLRN/acelyrin-adopt...
Small-cap stocks with improving money flow, Tue Mar 11th - #UFCS #ZVRA #RGR #TSVT #SLRN #RANI #QURE #PFC #MMLP #INBX #CRVO #BLTE - More: crystalequityresearch.com/SmCpStr/ - #smallcap
#SLRN ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger
www.stocktitan.net/news/SLRN/acelyrin-and-a...
#SLRN ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger
www.stocktitan.net/news/SLRN/acelyrin-deter...
#SLRN ACELYRIN Confirms Receipt of Unsolicited Indication of Interest from Concentra Biosciences
www.stocktitan.net/news/SLRN/acelyrin-confi...
#SLRN ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
www.stocktitan.net/news/SLRN/acelyrin-inc-a...
#SLRN ACELYRIN, INC. Announces Topline Results From Phase 2b/3 Study of Izokibep for the Treatment of Uveitis
#news #investing #stocks
www.stocktitan.net/news/SLRN/acelyrin-inc-a...
🚨 Institutions #optionsvolume surge detected!
Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #AISP 254.0x
2. #POOL 240.4x
3. #ARKX 64.0x
4. #SLRN 38.6x
5. #PAY 24.0x
#OptionFlow #OptionsTrading #Trading
#SLRN ACELYRIN, INC. Reports Third Quarter 2024 Financial Results and Recent Highlights
www.stocktitan.net/news/SLRN/acelyrin-inc-r...